Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate

References

• American Academy of OphthalmologyGlaucomaBasic and Clinical Science Course2007–2008San Francisco, CA, USA
   Google Scholar
• The Advanced Glaucoma Intervention Study (AGIS)The relationship between control of intraocular pressure and visual field deteriorationAm J Ophthalmol200013042944011024415
   PubMed Web of Science ®Google Scholar
• KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trail determines that tropical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol200212070171312049574
   PubMed Web of Science ®Google Scholar
• HeijlALeskeMCBengtssonBReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol20021201268127912365904
   PubMed Web of Science ®Google Scholar
• Collaborative Normal-Tension Glaucoma Study GroupThe effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol19981264985059780094
   PubMed Web of Science ®Google Scholar
• LeskeMCHeijlAHusseinMEarly Manifest Glaucoma Trial Group: Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trialArch Ophthalmol2003121485612523884
   PubMed Web of Science ®Google Scholar
• MillsKBTrabeculectomy: a retrospective long-term follow-up of 444 casesBr J Ophthalmol1981657907957326225
   PubMed Web of Science ®Google Scholar
• ThomasJVSimmonsRJBelcherCD3rdArgon laser trabeculoplasty in the presurgical glaucoma patientOphthalmology1982891871977088501
   PubMed Web of Science ®Google Scholar
• HeelRCBrogdenRNSpeightTMAveryGSTimolol: a review of its therapeutic efficacy in the topical treatment of glaucomaDrugs1979173855369807
   PubMed Web of Science ®Google Scholar
• AlexanderCLMillerSJAbelSRProstaglandin analog treatment of glaucoma and ocular hypertensionAnn Pharmacother20023650451111895065
   PubMed Web of Science ®Google Scholar
• AlmAStjernschantzJEffects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study GroupOphthalmology1995102174317529098273
   PubMed Web of Science ®Google Scholar
• WatsonPGLatanoprost. Two years’ experience of its use in the United Kingdom. Latanoprost Study GroupOphthalmology199810582879442782
   PubMed Web of Science ®Google Scholar
• LarssonLIEffect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertensionJ Glaucoma20011010911411316092
   PubMed Web of Science ®Google Scholar
• LarssonLIThe effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertensionActa Ophthalmol Scand20017912512811284748
   PubMedGoogle Scholar
• PfeifferNEuropean Latanoprost Fixed Combination Study GroupA comparison of the fixed combination of latanoprost and timolol with its individual componentsGraefes Arch Clin Exp Ophthalmol200224089389912486510
   PubMed Web of Science ®Google Scholar
• SchumanJSKatzGJLewisRAEfficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertensionAm J Ophthalmol200514024225016086946
   PubMed Web of Science ®Google Scholar
• HommerAGanfort Investigators Group IA double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertensionEur J Ophthalmol200717536217294383
   PubMed Web of Science ®Google Scholar
• MartinezASanchezMA comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucomaCurr Med Res Opin2007231025103217519068
   PubMed Web of Science ®Google Scholar
• MartinezASanchezMBimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patientsEye (Lond)20092381081818535605
   PubMed Web of Science ®Google Scholar
• BonomiLMarchiniGMarraffaVascular risk factors for primary open angle glaucoma: the Egna-Neumarkt StudyOphthalmology20001071287129310889099
   PubMed Web of Science ®Google Scholar
• SeilerTWollensakJThe resistance of the trabecular meshwork to aqueous humor outflowGraefes Arch Clin Exp Ophthalmol198522388914007511
   PubMed Web of Science ®Google Scholar
• TorisCBCamrasCBYablonskiMEEffects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyesOphthalmology1993100129713048371915
   PubMed Web of Science ®Google Scholar
• CoakesRLBrubakerRFThe mechanism of timolol in lowering intraocular pressure. In the normal eyeArch Ophthalmol19789620452048363105
   PubMed Web of Science ®Google Scholar
• TorisCBGleasonMLCamrasCBYablonskiMEEffects of brimonidine on aqueous humor dynamics in human eyesArch Ophthalmol1995113151415177487618
   PubMed Web of Science ®Google Scholar
• UusitaloRJPalkamaALong-term evaluation of timololActa Ophthalmol (Copenh)1989675735812686343
   PubMed Web of Science ®Google Scholar
• RuloAHGreveELHoyngPFAdditive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressureBr J Ophthalmol1994788999027819171
   PubMed Web of Science ®Google Scholar
• PatelSCSpaethGLCompliance in patients prescribed eyedrops for glaucomaOphthalmic Surg1995262332367651690
   PubMedGoogle Scholar
• DayDGSchacknowPNWandMTimolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertensionAm J Ophthalmol200313513814312566015
   PubMed Web of Science ®Google Scholar